You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
福森藥業(1652.HK)連漲3日累漲24.66% 明日即將公佈業績
格隆匯 03-30 16:50
格隆匯3月30日丨“十四五”規劃支持中醫藥特色創新發展,帶動港股市場中藥概念股集體走強。其中,福森藥業(1652.HK)大漲11.52%報4.55港元,為連續第三日上漲,三個交易日已累漲24.66%,股價創今年2月17日以來新高,最新市值35億港元。值得注意的是,公司即將於明日公佈業績,此前公司發佈業績預吿稱,由於市場需求增加,推動集團的主要產品雙黃連口服液銷售額增加,預計集團2020年股東應占溢利為人民幣6300萬-7500萬元,同比增加約21%至44%。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account